Till the time the Nifty does not surpass the 19,550 – 19,600 level on a closing basis, one should avoid being complacent and ideally, it’s better to avoid aggressive trades, according to experts

Read More

​ Till the time the Nifty does not surpass the 19,550 – 19,600 level on a closing basis, one should avoid being complacent and ideally, it’s better to avoid aggressive trades, according to experts Till the time the Nifty does not surpass the 19,550 – 19,600 level on a closing basis, one should avoid being complacent and ideally, it’s better to avoid aggressive trades, according to experts  Moneycontrol Latest News Read More  

Till the time the Nifty does not surpass the 19,550 – 19,600 level on a closing basis, one should avoid being complacent and ideally, it’s better to avoid aggressive trades, according to experts

MSCI#39;s broadest index of Asia-Pacific shares outside Japan were a fraction lower in thin trade, after losing 2.3% last week.

Read More

​ MSCI#39;s broadest index of Asia-Pacific shares outside Japan were a fraction lower in thin trade, after losing 2.3% last week. MSCI#39;s broadest index of Asia-Pacific shares outside Japan were a fraction lower in thin trade, after losing 2.3% last week.  Moneycontrol Latest News Read More  

MSCI#39;s broadest index of Asia-Pacific shares outside Japan were a fraction lower in thin trade, after losing 2.3% last week.

MSCI#39;s broadest index of Asia-Pacific shares outside Japan were a fraction lower in thin trade, after losing 2.3% last week.

Read More

​ MSCI#39;s broadest index of Asia-Pacific shares outside Japan were a fraction lower in thin trade, after losing 2.3% last week. MSCI#39;s broadest index of Asia-Pacific shares outside Japan were a fraction lower in thin trade, after losing 2.3% last week.  Moneycontrol Latest News Read More  

MSCI#39;s broadest index of Asia-Pacific shares outside Japan were a fraction lower in thin trade, after losing 2.3% last week.

The agreement “will enhance SAMI#39;s role in supporting the national defence industry and strengthening our local capabilities,” SAMI said.

Read More

​ The agreement “will enhance SAMI#39;s role in supporting the national defence industry and strengthening our local capabilities,” SAMI said. The agreement “will enhance SAMI#39;s role in supporting the national defence industry and strengthening our local capabilities,” SAMI said.  Moneycontrol Latest News Read More  

The agreement “will enhance SAMI#39;s role in supporting the national defence industry and strengthening our local capabilities,” SAMI said.

In a statement, Warner Bros. said the fantasy-comedy movie has taken in $459 million from domestic theaters – counting the United States and Canada – and another $572.1 million overseas since it hit theaters, for a total of $1.0315 billion. The figure was confirmed by media analytics firm Comscore.

Read More

​ In a statement, Warner Bros. said the fantasy-comedy movie has taken in $459 million from domestic theaters – counting the United States and Canada – and another $572.1 million overseas since it hit theaters, for a total of $1.0315 billion. The figure was confirmed by media analytics firm Comscore. In a statement, Warner Bros. said the fantasy-comedy movie has taken in $459 million from domestic theaters – counting the United States and Canada – and another $572.1 million overseas since it hit theaters, for a total of $1.0315 billion. The figure was confirmed by media analytics firm Comscore.  Moneycontrol Latest News Read More  

In a statement, Warner Bros. said the fantasy-comedy movie has taken in $459 million from domestic theaters – counting the United States and Canada – and another $572.1 million overseas since it hit theaters, for a total of $1.0315 billion. The figure was confirmed by media analytics firm Comscore.

In a statement, Warner Bros. said the fantasy-comedy movie has taken in $459 million from domestic theaters – counting the United States and Canada – and another $572.1 million overseas since it hit theaters, for a total of $1.0315 billion. The figure was confirmed by media analytics firm Comscore.

Read More

​ In a statement, Warner Bros. said the fantasy-comedy movie has taken in $459 million from domestic theaters – counting the United States and Canada – and another $572.1 million overseas since it hit theaters, for a total of $1.0315 billion. The figure was confirmed by media analytics firm Comscore. In a statement, Warner Bros. said the fantasy-comedy movie has taken in $459 million from domestic theaters – counting the United States and Canada – and another $572.1 million overseas since it hit theaters, for a total of $1.0315 billion. The figure was confirmed by media analytics firm Comscore.  Moneycontrol Latest News Read More  

In a statement, Warner Bros. said the fantasy-comedy movie has taken in $459 million from domestic theaters – counting the United States and Canada – and another $572.1 million overseas since it hit theaters, for a total of $1.0315 billion. The figure was confirmed by media analytics firm Comscore.

The space agency said it will carry out the next such operation on August 9.

Read More

​ The space agency said it will carry out the next such operation on August 9. The space agency said it will carry out the next such operation on August 9.  Moneycontrol Latest News Read More  

The space agency said it will carry out the next such operation on August 9.

Motilal Oswal is bullish on Varun Beverages recommended buy rating on the stock with a target price of Rs 940 in its research report dated August 03, 2023.

Read More

​ Motilal Oswal is bullish on Varun Beverages recommended buy rating on the stock with a target price of Rs 940 in its research report dated August 03, 2023. Motilal Oswal is bullish on Varun Beverages recommended buy rating on the stock with a target price of Rs 940 in its research report dated August 03, 2023.  Moneycontrol Latest News Read More  

Motilal Oswal is bullish on Varun Beverages recommended buy rating on the stock with a target price of Rs 940 in its research report dated August 03, 2023.

Motilal Oswal is bullish on Sun Pharma recommended buy rating on the stock with a target price of Rs 1310 in its research report dated August 03, 2023.

Read More

​ Motilal Oswal is bullish on Sun Pharma recommended buy rating on the stock with a target price of Rs 1310 in its research report dated August 03, 2023. Motilal Oswal is bullish on Sun Pharma recommended buy rating on the stock with a target price of Rs 1310 in its research report dated August 03, 2023.  Moneycontrol Latest News Read More  

Motilal Oswal is bullish on Sun Pharma recommended buy rating on the stock with a target price of Rs 1310 in its research report dated August 03, 2023.

Motilal Oswal is bullish on Sun Pharma recommended buy rating on the stock with a target price of Rs 1310 in its research report dated August 03, 2023.

Read More

​ Motilal Oswal is bullish on Sun Pharma recommended buy rating on the stock with a target price of Rs 1310 in its research report dated August 03, 2023. Motilal Oswal is bullish on Sun Pharma recommended buy rating on the stock with a target price of Rs 1310 in its research report dated August 03, 2023.  Moneycontrol Latest News Read More  

Motilal Oswal is bullish on Sun Pharma recommended buy rating on the stock with a target price of Rs 1310 in its research report dated August 03, 2023.